Affiliation:
1. Institute of Science, Technology, and Society, National Yang-Ming University
Abstract
This study explores the social dynamics in promoting traditional Chinese medicine (tcm) drugs by making them acceptable to biomedical markets. It investigates the Consortium for Globalization of Chinese Medicine (cgcm), an organisation based in Hong Kong in pursuit of advancing tcm, and traces the development of the herbal formula phy906, a Chinese herbal product intensively discussed at the cgcm that has been tested according to the us Food and Drug Administration’s regulation for approval. Departing from accounts on the organisation’s success that focus either on its scientific approach or its leader Yung-chi Cheng, this paper argues that it was the synergy between the cgcm and the pursuit of approval for phy906 that contributed to the regulatory globalisation of tcm. In this process, not only organisations like the cgcm are required to streamline efforts for producing globalised tcm; also researchers are needed who, with cultural commitment, seek for transforming tcm to meet biomedical indications.
Subject
Medicine (miscellaneous),Complementary and alternative medicine,Arts and Humanities (miscellaneous)
Reference26 articles.
1. ‘Botanical and Plant-Derived Drugs: Global Markets’,2015
2. ‘New Therapies from Old Medicines’;Chen;Nature Biotechnology,2008
3. ‘Composition Consisting of phy906 and Chemotherapeutic Agents’;Cheng,2001
4. ‘Conversations between Chief Executive Chee-hwa Tung and Legislative Council Members’;China.org.cn,2001
5. ‘Phase i/iia Randomized Study of phy906, a Novel Herbal Agent, as a Modulator of Chemotherapy in Patients with Advanced Colorectal Cancer’;Farrell;Clinical Colorectal Cancer,2003
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Glossary;Mao's Bestiary;2021-04-23
2. Bibliography;Mao's Bestiary;2021-04-23
3. Notes;Mao's Bestiary;2021-04-23
4. Conclusion;Mao's Bestiary;2021-04-23
5. “Economic Animals”;Mao's Bestiary;2021-04-23